Coronavirus Vaccine: Oxford's Corona Virus Vaccine May Bring Good News Today!

Read Time:1 Minute, 33 Second

Coronavirus Vaccine was reported in a positive news that there may be good news about the initial trial of the Oxford / AstraZeneca Kovid-19 vaccine on Thursday.

New Delhi, Lifestyle Desk. Coronavirus Vaccine: The corona virus that started in Wuhan city of China last year continues to wreak havoc across the world. Since then, scientists from many countries of the world have been working together to prepare a safe vaccine to fight this virus.

There is a dire need for a safe vaccine at this time to stop Kovid-19. Which not only reduces the risk of this dangerous disease, but can also prevent deaths from it. There was a positive news in this matter on Wednesday, which stated that on Thursday i.e. today, there may be good news about the

initial trial of Oxford / AstraZeneca’s COVID-19 vaccine.

The news came as American biotech company Moderna announced that it was planning to begin testing the final third phase of its experimental corona virus vaccine on July 27. A first-stage trial found that Modrna’s mRNA-1273 vaccine against SARS-CoV-2 is absolutely safe, and also strengthens the immune system against viruses.

The potential COVID-19 vaccine ChAdOx1 nCoV-19 to be developed at the Oxford Jenner Institute of the University of Oxford has been licensed to AstraZeneca. It has already reached the third stage of large-scale human trials to determine whether this vaccine can protect against SARS-CoV-2 infection.

Oxford’s ChAdOx1 nCoV-19 Vaccine

The ChAdOx1 nCoV-19 vaccine is produced from a weak and non-replicating variant of the common cold virus called ChAdOx1. According to the information, the experimental COVID-19 vaccine is designed to express the SARS-CoV-2 spike protein. This vaccine is made by mixing genetic material called spike glycoproteins.